Hsbc Holdings PLC Moderna, Inc. Call Options Transaction History

Hsbc Holdings PLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $1.7 Million - $2.95 Million	46,100 New	46,100 $1.92 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $136,592 - $184,704	1,600 New	1,600 $170,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $153,894 - $273,052	1,300 Added 12.26%	11,900 $2.14 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $843,336 - $1.27 Million	7,200 Added 211.76%	10,600 $1.54 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $214,982 - $399,585	1,700 Added 100.0%	3,400 $596,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $722,624 - $1.18 Million	-3,200 Reduced 65.31%	1,700 $431,000
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $207,856 - $375,968	1,600 Added 48.48%	4,900 $1.15 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $360,294 - $613,734	3,300 New	3,300 $432,000

924

256M

19M

24.3M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.